A study of pretreatment nomograms to predict pathological stage and biochemical recurrence after radical prostatectomy for clinically resectable prostate cancer in Japanese Men

Japanese Journal of Clinical Oncology

Volumn 31, Issue 2, 2001, Pages 74-81

  Egawa, Shin ^a   Suyama, Kazuho ^a   Arai, Yoichi ^b   Matsumoto, Kazumasa ^a   Tsukayama, Chotatsu ^b   Kuwao, Sadahito ^a   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Biochemical failure; Nomogram; Pathological stage; Prostate cancer; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BIOCHEMISTRY; CANCER RECURRENCE; CANCER STAGING; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE MARKER; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NOMOGRAM; PATIENT COUNSELING; POPULATION RISK; PREDICTION; PROSTATE CANCER; PROSTATECTOMY; REGRESSION ANALYSIS; RISK ASSESSMENT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0035068861     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hye018     Document Type: Article

References (18)

1. Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localized prostate cancer
2. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
3. The use of prostate specific antigen, clinical stage and Gleason score to predict patholigical stage in men with localized prostate cancer
4. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer
5. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer
6. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer
7. Early detection of prostate cancer. Results of a prostate specific antigen-based detection program in Japan
8. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests
9. Efficacy and limitations of delayed/salvage radiation therapy after radical prostatectomy
10. Androgen ablation in addition to radiation therapy for prostate cancer: Is there true benefit?
11. Evaluation and management of men whose radical prostatectomies failed: Results of an international survey
12. Evaluation of AxSYM automated immunoassay analyzer system for determining prostate-specific antigen and comparison of reactiveness for the antigen and diagnostic values of several commercial kits
13. Improved predictability of extracapsular extension and seminal vesicle involvement based on clinical and biopsy findings in prostate cancer in Japanese men
14. Preoperative serum prostate-specific antigen, clinical stage and Gleason sum as basis for predicting final pathological stage in Japanese patients with prostate cancer
15. Evaluation of a nomogram used to predict the pathologic stage of clinically localized prostate carcinoma
16. Infrequent involvement of the anterior base in low-risk patients with clinically localized prostate cancer and its possible significance in definitive radiation therapy
17. Natural history of progression after PSA elevation following radical prostatectomy